×
-0.0083760683760684 -0.0083760683760684 0.0256410256410255 0.0256410256410255 0.0598290598290597 0.0254700854700853 0.00820512820512806 -0.0360683760683763
Stockreport

Akers Bio beefs up U.S. distribution for Heparin PF4 rapid test; shares up 7% premarket [Seeking Alpha]

AKERS BIOSCIENCES INC COMMON S (AKER)  More Company Research Source: Seeking Alpha
US:NASDAQ Investor Relations: akersbio.com/investor-center
PDF Akers Bio beefs up U.S. distribution for Heparin PF4 rapid test; shares up 7% premarketNano cap Akers Biosciences (NASDAQ:AKER) is up7% premarket on average volume in response to itsannouncement that it has engaged two new U.S. distributors for its point-of-care PIFA Heparin/PF4 Rapid Assay.Newtown, PA-based Opto-Systems will provide additional coverage in the Northeast while Sacramento, CA-based Herzog Surgical will do the same in Nevada and California.See all stocks on the move »Now read:ImmunoCellular advances Stem-to-T-Cell technology; shares up 27% premarket » [Read more]

IMPACT SNAPSHOT EVENT TIME: AKER
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AKER alerts

from News Quantified
Opt-in for
AKER alerts

from News Quantified